John Paulson's investment portfolio, managed by Paulson & Company, experienced a reduction in value during the first quarter of 2026, settling at approximately $3.11 billion. This concentrated portfolio primarily held nine securities, with a significant majority, around 87%, stemming from the top five positions. The modifications within the portfolio indicate a clear strategic direction, focusing on substantial stakes in specific sectors.
Key adjustments in this period included a notable increase in mining sector investments, alongside a decrease in pharmaceutical holdings. Despite these shifts, Paulson maintained considerable, enduring positions in several companies, underscoring a commitment to long-term value and active management. This approach reflects an emphasis on identifying and capitalizing on deep value opportunities within the market.
Strategic Portfolio Adjustments and Key Holdings
In the initial quarter of 2026, John Paulson's portfolio at Paulson & Company underwent significant rebalancing, leading to a total valuation of approximately $3.11 billion. The portfolio's highly concentrated nature is evident, with its top five investments comprising a substantial 87% of its overall value. This concentration highlights a strategic approach centered on high-conviction positions rather than broad diversification.
A notable move during this period involved a 42% increase in his stake in International Tower Hill Mines, demonstrating a reinforced belief in the mining sector. Conversely, Paulson significantly trimmed his position in Madrigal Pharma by 19%, suggesting a reevaluation of its prospects or a reallocation of capital to other opportunities. His largest holding, Perpetua Resources, accounted for 29.23% of the portfolio, where Paulson maintained a considerable 31% ownership, signaling strong confidence in its long-term potential.
Enduring Convictions and Future Outlook
Paulson's investment philosophy continues to emphasize long-term commitments and substantial influence within his chosen companies. Beyond the transactional adjustments, the portfolio reveals steadfast positions in firms such as Bausch Health, NovaGold, and Acadian Asset Management. These holdings represent enduring convictions in their underlying value and strategic importance to Paulson's investment thesis.
The sustained presence of these investments in his portfolio, despite broader market shifts, underscores a deep-value strategy. Paulson’s preference for significant ownership allows him to exert considerable influence, aligning with his history of active engagement in company governance and strategic direction. This long-term, high-conviction approach positions the portfolio to capitalize on future growth and recovery in specific sectors, reflecting a patient and focused investment strategy.
